Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma

Published:2015-10-07 Issue:11 Volume:106 Page:1576-1581
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Okamoto Akinao¹,Yanada Masamitsu¹,Miura Hiroki²,Inaguma Yoko¹,Tokuda Masutaka¹,Morishima Satoko¹,Kanie Tadaharu¹,Yamamoto Yukiya¹,Mizuta Shuichi¹,Akatsuka Yoshiki¹,Yoshikawa Tetsushi²,Mizoguchi Yoshikazu³,Nakamura Shigeo⁴,Okamoto Masataka¹,Emi Nobuhiko¹

Affiliation:

1. Department of Hematology Fujita Health University School of Medicine Toyoake Japan

2. Department of Pediatrics Fujita Health University School of Medicine Toyoake Japan

3. Department of Pathology Fujita Health University School of Medicine ToyoakeJapan

4. Department of Pathology and Laboratory Medicine Nagoya University Hospital Nagoya Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12812

Reference37 articles.

1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

2. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

3. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

5. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBV‐Positive Pleomorphic Variant Transformation of CD5‐Negative Mantle Cell Lymphoma: A Rare Case Report and Literature Review;Case Reports in Hematology;2024-01

2. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS;Heliyon;2024-01

3. Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy;Gastric Cancer;2023-11-29

4. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma;Journal of Pharmacology and Experimental Therapeutics;2023-10-24

5. Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis with Central Nervous System Symptoms;Journal of Nippon Medical School;2023-02-25